Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Chugai Seiyaku Kabushiki Kaisha
Chugai Seiyaku Kabushiki Kaisha A Japanese Corporation
Chugai Seiyaku Kabushiki Kaisha A Corporation Of Japan
Chugai Seiyaku Kabushiki Kaisha A Japanese Corporation_20100121
Chugai Seiyaku Kabushiki Kaisha_20100121
Chugai Seiyaku Kabushiki Kaisha_20131212
Chugai Seiyaku Kabushiki Kaisha_20100128
Chugai Seiyaku Kabushiki Kaisha_20100107
  

Chugai Seiyaku Kabushiki Kaisha patents

Recent patent applications related to Chugai Seiyaku Kabushiki Kaisha. Chugai Seiyaku Kabushiki Kaisha is listed as an Agent/Assignee. Note: Chugai Seiyaku Kabushiki Kaisha may have other listings under different names/spellings. We're not affiliated with Chugai Seiyaku Kabushiki Kaisha, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Chugai Seiyaku Kabushiki Kaisha-related inventors




Date Chugai Seiyaku Kabushiki Kaisha patents (updated weekly) - BOOKMARK this page
07/20/17Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
07/13/17Syringe cap, syringe with needle, and prefilled syringe formulation
06/01/17Diagnosis and treatment of cancer using anti-desmoglein-3 antibodies
05/25/17Antibody substituting for function of blood coagulation factor viii
05/11/17Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient
05/04/17Pharmaceutical composition comprising non-ionic surfactants
05/04/17Anti-il-6 receptor antibody
04/27/17Hydantoin derivative-containing pharmaceutical composition
04/27/17Stable protein-containing preparation containing argininamide or analogous compound thereof
03/23/17Novel crystal of tetracyclic compound
03/16/17Gpc3-targeting drug which is administered to patient responsive to gpc3-targeting drug therapy
02/09/17Preparation containing tetracyclic compound at high dose
01/26/17Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
01/26/17Preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
01/26/17Immunoactivating antigen-binding molecule
01/26/17Nucleic acid encoding bispecific antibodies
01/12/17Method for assaying soluble gpc3 protein
01/05/17Antibodies with modified affinity to fcrn that promote antigen clearance
01/05/17Antibodies with modified affinity to fcrn that promote antigen clearance
11/24/16Tetracyclic compound
11/10/16Solid preparations containing tofogliflozin and process of producing the same
11/10/16Hydantoin derivative
11/10/16Method for purifying antibody having low isoelectric point
11/10/16Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient
11/03/16Composition comprising tetracyclic compound
11/03/16Fgfr gatekeeper mutant gene and drug targeting same
11/03/16Inhibitors of bruton's tyrosine kinase
10/27/16Inhibitors of bruton's tyrosine kinase
10/27/16Peptide-compound cyclization method
10/27/16Diagnosis and treatment of cancer using anti-itm2a antibody
10/20/16Inhibitors of bruton's tyrosine kinase
10/20/16Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules
09/29/16Antigen-binding molecule containing modified antibody variable region
09/22/16Quinazolinone and isoquinolinone derivative
09/15/16Method for producing antigen-binding molecule using modified helper phage
08/25/16Antibodies with modified affinity to fcrn that promote antigen clearance
08/25/16Anti-dll3 antibody
08/11/16Antibodies comprising an ion concentration dependent antigen-binding domain, fc region variants, il-8-binding antibodies, and uses thereof
08/11/16Method for producing polypeptide heteromultimer
08/11/16Treatment for hemorrhagic diseases by anti-protein-c antibody
08/04/16Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
07/21/16Use of rhoa in cancer diagnosis and inhibitor screening
07/14/16Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
07/07/16Therapeutic agent for chronic arthritides diseases of childhood-related diseases
06/30/16Method for the production of a glycosylated immunoglobulin
06/23/16Anti-c5 antibodies and methods of use
06/16/16Method for cancer immunotherapy
06/16/16Pharmaceutical compositions containing sc(fv)2
06/09/16Cancer stem cell-specific molecule
06/09/16Antibody constant region variant
06/09/16Therapeutic agent comprising humanized anti-epiregulin antibody as active ingredient for non-small-cell lung carcinoma excluding adenocarcinoma
06/02/16Subtypes of humanized antibody against interleukin-6 receptor
05/19/16Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (rrms) patient, and determining applicability of novel therapy
03/31/16High concentration antibody-containing liquid formulation
02/25/16Monoclonal antibody capable of binding to anexelekto, and use thereof
02/18/16Antigen-binding molecule for promoting disappearance of antigen via fc gamma riib
02/11/16Fc region variant
01/28/16Therapeutic agents for pancreatic cancer
01/21/16Spiroimidazolone derivative
01/21/16Pharmaceutical composition containing antagonist of egf family ligand as component
01/07/16Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same
12/24/15Anti-dll3 antibody
12/10/15Antigen-binding molecule for eliminating aggregated antigens
12/03/15Heterodimerized polypeptide
11/05/15Anti-glypican-3 antibody having improved kinetics in plasma
Patent Packs
11/05/15Preventive or remedy for inflammatory disease
11/05/15Method of producing heterogeneous protein
10/29/15Fgfr3 fusion gene and pharmaceutical drug targeting same
10/22/15Fcgammariib-specific fc region variant
10/22/15Antigen-binding molecule for promoting clearance from plasma of antigen comprising suger chain receptor-binding domain
10/15/15Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
10/08/15Method of modifying isoelectric point of antibody via amino acid substitution in cdr
10/08/15Stabilized antibody-containing formulations
10/08/15Gpc3-targeting drug which is administered to patient responsive to gpc3-targeting drug therapy
10/01/15Ret inhibitor
10/01/15Hydantoin derivative
10/01/15Antibody constant region variant
10/01/15Method for establishing modified host cell
09/17/15Anti-glypican 3 antibody
09/17/15Method for manufacturing solar cell, and solar cell
Patent Packs
09/03/15Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
08/27/15Pharmaceutical preparation comprising aminopyrazole derivative
08/27/15Method for evaluating blood coagulation reaction
08/20/15Hyaluronic acid derivative having amino acid and steryl group introduced thereinto
08/13/15Gene knock-in non-human animal
07/30/15Orally available viridiofungin derivative possessing anti-hcv activity
07/30/15Modified fc region of antibody
07/23/15Mouse fcgammarii-specific fc antibody
07/23/15Mouse fcgammarii-specific fc antibody
07/09/15Preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
06/25/15Anti-nr10 antibody and use thereof
06/18/15Antigen-binding molecule containing modified fc region
06/18/15Target tissue-specific antigen-binding molecule
06/18/15Antibody molecules that bind to il-6 receptor
06/04/15Tetracyclic compound
06/04/15Benzamide derivative
05/21/15Quinazolinedione derivative
05/07/15Urokinase-type plasminogen activator transgenic mouse
04/30/15Anti-lamp5 antibody and utilization thereof
04/23/15Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient
04/09/15Anti-glypican-3 antibody
03/19/15Chimeric fc-gamma receptor and determination of adcc activity by using the receptor
03/19/15Peptide-compound cyclization method
02/26/15Drug containing carrier into cell for forming immune complex
02/19/15Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
02/05/15Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
01/08/15Methods for treating interleukin-6 related diseases
12/25/14Subtypes of humanized antibody against interleukin-6 receptor
12/25/14Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
12/18/14Multi-specific antigen-binding molecules and uses thereof
Social Network Patent Pack
12/18/14Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain
12/11/14Therapeutic antigen-binding molecule with a fcrn-binding domain that promotes antigen clearance
11/13/14Antigen-binding molecule for promoting elimination of antigens
10/23/14Aminopyrazole derivative
10/09/14Cancer stem cell-specific molecule
09/18/14Ion concentration-dependent binding molecule library
09/11/14Antigen-binding molecule inducing immune response to target antigen
09/04/14Novel anti-ddr1 antibody having anti-tumor activity
08/21/14Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
07/31/14Method for producing coumarin derivative
Patent Packs
07/24/14Stable protein-containing preparation containing argininamide or analogous compound thereof
07/17/14Heterodimerized polypeptide
05/29/14Diagnosis and treatment of cancer using anti-gpr49 antibody
04/24/14Cytotoxicity-inducing therapeutic agent
04/17/14Method for altering plasma retention and immunogenicity of antigen-binding molecule
04/03/14Fc-gamma-riib-specific fc antibody
03/20/14Preventive agent for vasculitis
03/20/14Method for improving physical properties of antibody
02/13/14Method for cancer immunotherapy
02/06/14Multi-specific antigen-binding molecules and uses thereof
02/06/14Anti-nr10 antibody and use thereof
01/30/14Recombinant polypeptide production method
01/23/14Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
01/16/14Methods for treating interleukin-6 related diseases
01/09/14Process for producing water-soluble hyaluronic acid modification
01/02/14High concentration antibody-containing liquid formulation
12/19/13Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
12/19/13Derivative of hyaluronic acid modified with amino-carboxylic acid
12/12/13Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
11/28/13Anti-il-6 receptor antibody
11/07/13Animal cell culturing method
08/29/13Protein purification method
08/15/13Subtypes of humanized antibody against interleukin-6 receptor
08/08/13Antitumor t cell response enhancer
05/23/13Antibodies with modified affinity to fcrn that promote antigen clearance
05/16/13Combination of a pi3k inhibitor and a mek inhibitor
05/09/13Novel hemopoietin receptor protein, nr10
04/25/13Antibody constant region variant
01/24/13Stabilized antibody-containing liquid formulations
01/17/13Polypeptide modification purifying polypeptide multimers
Patent Packs
01/10/13Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
10/25/12Spiroimidazolone derivative
10/04/12Antibody molecules that bind to il-6 receptor
09/27/12Antibody capable of recognizing hla class i
09/20/12Antibody substituting for function of blood coagulation factor viii
09/20/12Modified antibody constant regions
08/30/12Organic cation transporter polypeptides
08/16/12Aminopyrazole derivative
07/19/12Process for producing water-soluble hyaluronic acid modification
06/21/12Tumor suppressor gene
06/21/12Humanized anti-cd47 antibody
06/07/12Method for production of polypeptide
05/24/12Systemic carnitine deficiency gene and uses thereof
05/17/12Anti-axl antibody
04/05/12Tetracyclic compound
03/22/12Antibody constant region variant
03/22/12Prevention and treatment of blood coagulation-related disases
03/15/12Antibody constant region variant
01/19/12Degraded tpo agonist antibody
12/15/11Novel imidazolidine derivative and use thereof
Social Network Patent Pack
12/01/11Vegf-like factor antibodies and methods of use thereof
11/17/11Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus
11/17/111-(2h)-isoquinolone derivative
11/10/11Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes
11/03/11Preventive or therapeutic agent for psoriatic arthritis comprising il-6 antagonist as active ingredient
10/20/11Method for screening candidate compounds for antitumor drug
10/06/11Anti-il-6 receptor antibody
09/22/11Anti-nr10 antibody and use thereof
09/22/11Cancer-associated antigen analogue peptides and uses thereof
09/15/11Therapeutic agent for hematopoietic tumors
09/01/11Hyaluronic acid derivative and pharmaceutical composition thereof
08/25/11Therapeutic agent for chronic arthritides diseases of childhood-related diseases
08/25/11Peptide-containing culture medium for culturing animal cell
08/25/11Method for measuring inhibitory activity on ligand-receptor binding
06/23/11Neuroinvasion inhibitor
06/09/11Cell culture method using amino acid-enriched medium
06/02/11Anti-nr10 antibody and use thereof
05/12/11Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
05/05/11Liver cancer drug
04/28/11Antibody molecules
Social Network Patent Pack
04/28/11Method of producing compound having anti-hcv activity
04/21/11Method for detection of liver cancer cell using anti-glypican-3 antibody
04/14/11Cytokine-like proteins
04/07/11Gene overexpressed in cancer
03/31/11Method of modifying isoelectric point of antibody via amino acid substitution in cdr
03/17/11Method of producing fused protein
03/10/11Anti-mpl antibodies
03/10/11Vitamin-d-like compounds
02/24/11Monoclonal antibody capable of binding to anexelekto, and use thereof
02/10/11Anti-glypican 3 antibody having modified sugar chain
01/20/11Cell for use in prouduction of heteroproteins and production method using the same
01/06/11Cell growth inhibitors containing anti-glypican 3 antibody
12/30/10Uses of sperm membrane protein obf
12/30/10Method for identifying within a mammal a dna encoding a physiologically active polypeptide
12/30/10Human tissue factor-producing knock-in non-human animal
12/23/10Pyrrolopyrimidine derivative as p13k inhibitor and use thereof
12/09/10Therapeutic agent for pruritus
12/02/10Ys68 gene involved in primitive hematopoiesis
11/25/10Modified antibody constant region
11/18/10Method for production of antibody
10/28/10Virus therapeutic drug
10/14/10Process for producing vitamin d derivative using photoreaction
10/07/10Therapeutic agents for graft-versus-host disease comprising interleukin 6 receptor inhibitor as active ingredient
09/30/10Subtypes of humanized antibody against interleuken-6 receptor
09/30/10Antibodies that inhibit transport activity of peptide transporters
09/30/10Anti-glypican 3 antibody
09/23/10Anti-glypican-3 antibody having improved kinetics in plasma
09/16/10Method for production of polypeptide
09/16/10Erythropoietin solution preparation
08/26/10Methods for producing antibodies
Social Network Patent Pack
08/19/10Nucleic acids encoding the human alex1 protein
08/05/10Transporter genes oatp-b, c, d, and e
08/05/105-substituted-2-phenylamino benzamides as mek inhibitors
08/05/10Coumarin derivatives useful as tnf alpha inhibitors
07/22/10Antibody against secreted n-terminal peptide of gpc3 present in blood or c-terminal peptide of gpc3
07/15/10Benzamide derivative
07/08/10Igm production by transformed cell and quantifying the same
07/08/10Coumarin derivatives useful as tnf alpha inhibitors
07/01/10Method of producing heterogeneous protein
06/17/10Cell death inducer
06/17/10Intermediate compound for synthesis of viridiofungin a derivative
06/17/10Intermediate compound for synthesis of viridiofungin a derivative
05/27/10Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient
04/15/10Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same
04/15/10Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes
03/11/10Chronic rejection inhibitor
03/04/10Preventive or remedy for inflammatory disease
03/04/10Macrocyclic compound
02/18/10Agents for promoting the growth of hematopoietic stem cells
01/28/10Light-stabilized soft capsule formulations
01/21/10Methods for producing polypeptides by regulating polypeptide association
01/07/10Remedy for renal disease
01/07/10Antibody substituting for function of blood coagulation factor viii
12/31/09Methods for controlling blood pharmacokinetics of antibodies
12/31/09Novel process for the preparation of hexacyclic compounds
12/17/09Degraded agonist antibody
12/17/09Novel process for the preparation of hexacyclic compounds
12/03/09Structural isomers of sc(fv)2
11/26/09Stabilized antibody-containing formulations







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Chugai Seiyaku Kabushiki Kaisha in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Chugai Seiyaku Kabushiki Kaisha with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';